global health

Pharmalot By Ed Silverman

Dozens of institutional investors push for ‘fair and equitable’ Covid-19 response

Pharmalot By Ed Silverman

New pledges boost COVAX, but critics say more is needed to ensure global vaccine access

Health By Matthew Herper and Ed Silverman

Virtual Event: Facing the crisis of drug-resistant germs

Health By Andrew Joseph

‘What other variants might be out there?’ An expert on viral evolution on what’s happening with coronavirus mutations

Pharmalot By Ed Silverman

Pharma is only ‘inching forward’ in boosting access to medicines in low-income countries

First Opinion By Kate Dodson

Welcome back to the global health stage, America. You have a lot of work to do

Pharmalot By Ed Silverman

A Covid-19 vaccine maker in India stirs controversy over its clinical trial

First Opinion By Vas Narasimhan

Stopping the syndemic: Covid-19 plus other debilitating and deadly diseases

Health By Helen Branswell

3 global health issues to watch in 2021

First Opinion By Safura Abdool Karim

Emergency use authorization of Covid-19 vaccines could hinder global access to them

Pharmalot By Ed Silverman

Medicines Patent Pool expands deal for access to key HIV drug to several upper middle-income countries

First Opinion By Nathalie Strub-Wourgaft

Now is the time to innovate for more than 1 billion people with neglected tropical diseases

Pharmalot By Ed Silverman

‘Dying waiting’: Advocates urge Vertex to widen global access to cystic fibrosis drugs

Pharmalot By Ed Silverman

Hundreds of advocacy groups urge WTO to waive IP rights to Covid-19 drugs and vaccines

First Opinion By Danjuma Adda

Hepatitis is still a silent killer in Africa and elsewhere

Health By Adam Feuerstein

Inexpensive steroids reduce deaths of hospitalized Covid-19 patients, WHO analysis confirms

Health By Andrew Joseph

First Covid-19 reinfection documented in Hong Kong, researchers say

Health By Andrew Joseph, Helen Branswell, and Elizabeth Cooney

Seven months later, what we know about Covid-19 — and the pressing questions that remain

First Opinion By Tolbert Nyenswah

The DRC needs an Ebola survivor program to truly quell its outbreak

Health By Sharon Begley and Andrew Joseph

The U.S. is the accidental Sweden, which could make the fall ‘catastrophic’ for Covid-19

Health By Helen Branswell

WHO launches independent review of the international response to the Covid-19 pandemic

Pharmalot By Ed Silverman

Johnson & Johnson lowers the price of its TB drug in many poor countries, but is it enough?

Health By Andrew Joseph

WHO drops hydroxychloroquine from Covid-19 clinical trial

Health By Andrew Joseph

Immunity to the coronavirus remains a mystery. Scientists are trying to crack the case

Health By Andrew Joseph

WHO resumes hydroxychloroquine study for Covid-19, after reviewing safety concerns